Patents by Inventor Xiao-Bo Chen

Xiao-Bo Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12277698
    Abstract: A checking mechanism for workshop security applying a method for workshop security comprises a transmission device, a recording device, a storage subassembly and a control subassembly. The transmission device comprises a first end (115) and a second end (116). The recording device records personnel and objects in their possession through a security check process, to establish a correspondence. The storage subassembly stores the information comprising personnel and their objects. The control subassembly is used for controlling the recording device to record and store the information to the storage subassembly. The control subassembly can retrieve the information recorded by the recording device to detect a certain person's correspondence to the certain object.
    Type: Grant
    Filed: August 15, 2022
    Date of Patent: April 15, 2025
    Assignee: TRIPLE WIN TECHNOLOGY(SHENZHEN) CO. LTD.
    Inventor: Xiao-Bo Chen
  • Publication number: 20250043337
    Abstract: Provided herein are methods of assaying a methylated DNA-binding protein comprising contacting methylated DNA-binding proteins with labeled oligonucleotides, obtaining sample partitions for oligonucleotides with different methylation states, and quantifying the labeled oligonucleotides in the partitions.
    Type: Application
    Filed: May 10, 2024
    Publication date: February 6, 2025
    Inventors: Saiyou OHSHIMA, Kenneth Edmund STAPLETON, Dustin Howard HITE, Xiao-Bo CHEN, Chia-Hui LIN, Dania ANNUAR, Jessica Michelle PIERACCI
  • Publication number: 20230058003
    Abstract: A checking mechanism for workshop security applying a method for workshop security comprises a transmission device, a recording device, a storage subassembly and a control subassembly. The transmission device comprises a first end (115) and a second end (116). The recording device records personnel and objects in their possession through a security check process, to establish a correspondence. The storage subassembly stores the information comprising personnel and their objects. The control subassembly is used for controlling the recording device to record and store the information to the storage subassembly. The control subassembly can retrieve the information recorded by the recording device to detect a certain person’s correspondence to the certain object.
    Type: Application
    Filed: August 15, 2022
    Publication date: February 23, 2023
    Inventor: XIAO-BO CHEN
  • Patent number: 11548668
    Abstract: A sleeve wrapping device includes a first fixing base, a second fixing base, a first supporting frame protruded from the first fixing base, a second supporting frame protruded from the second fixing base, a first roller mounted on the first supporting frame, a second roller mounted on the second supporting frame, and a sleeve wrapping film comprising a substrate and a plurality of adhesive layers. The first roller and the second roller move back and forth relative to the first supporting frame and the second supporting frame. The sleeve wrapping device is switched between a first state that the first roller and the second roller are in contact with each other and a second state that the first roller and the second roller are separated. The substrate winds the first roller and the second roller.
    Type: Grant
    Filed: February 4, 2021
    Date of Patent: January 10, 2023
    Assignee: TRIPLE WIN TECHNOLOGY(SHENZHEN) CO.LTD.
    Inventors: Zi-Ling Chen, Xiao-Bo Chen
  • Publication number: 20210331818
    Abstract: A sleeve wrapping device includes a first fixing base, a second fixing base, a first supporting frame protruded from the first fixing base, a second supporting frame protruded from the second fixing base, a first roller mounted on the first supporting frame, a second roller mounted on the second supporting frame, and a sleeve wrapping film comprising a substrate and a plurality of adhesive layers. The first roller and the second roller move back and forth relative to the first supporting frame and the second supporting frame. The sleeve wrapping device is switched between a first state that the first roller and the second roller are in contact with each other and a second state that the first roller and the second roller are separated. The substrate winds the first roller and the second roller.
    Type: Application
    Filed: February 4, 2021
    Publication date: October 28, 2021
    Inventors: ZI-LING CHEN, XIAO-BO CHEN
  • Publication number: 20120237811
    Abstract: A lithium ion battery includes an anode plate and a cathode plate spirally coiled with a separator set between the anode plate and the cathode plate. The cathode plate includes a cathode current collector and a cathode film on the cathode current collector. The cathode current collector is formed with a number of cathode extending portions along a length direction thereof. The anode plate includes an anode current collector and an anode film on the anode current collector. The anode current collector is formed with a number of anode extending portions along a length direction thereof. After the cathode plate, the anode plate and the separator are coiled as a battery cell, the cathode extending portions are combined to form a cathode lead, and the anode extending portions are combined to form an anode lead. Before manufacture, the compacted cathode plate/anode plate is baked.
    Type: Application
    Filed: March 15, 2012
    Publication date: September 20, 2012
    Applicant: DONGGUAN AMPEREX TECHNOLOGY LIMITED
    Inventors: Heng-tao Xia, Yue-li Wang, Jian-Jiang Wel, Xiao-bo Chen, Zhi-feng He
  • Publication number: 20100151489
    Abstract: Disclosed embodiments concern quantifying a biomolecule conjugated to a nanoparticle. Quantifying typically comprises determining the number of biomolecules per nanoparticle. Any suitable biomolecule can be used, including but not limited to, amino acids, peptides, proteins, haptens, nucleic acids, oligonucleotides, DNA, RNA, and combinations thereof. A single type of biomolecule may be conjugated to the nanoparticle, more than one biomolecule of a particular class may be conjugated to the nanoparticle, or two or more classes of biomolecules may be conjugated to the nanoparticle. Certain disclosed embodiments comprise enzymatically or chemically digesting a biomolecule conjugated to the nanoparticle, or displacing a biomolecule using ligand-exchange chemistry.
    Type: Application
    Filed: February 1, 2010
    Publication date: June 17, 2010
    Inventors: Xiao-Bo Chen, Christopher Bieniarz, Michael Farrell
  • Patent number: 7682789
    Abstract: Disclosed embodiments concern quantifying a biomolecule conjugated to a nanoparticle. Quantifying typically comprises determining the number of biomolecules per nanoparticle. Any suitable biomolecule can be used, including but not limited to, amino acids, peptides, proteins, haptens, nucleic acids, oligonucleotides, DNA, RNA, and combinations thereof. A single type of biomolecule may be conjugated to the nanoparticle, more than one biomolecule of a particular class may be conjugated to the nanoparticle, or two or more classes of biomolecules may be conjugated to the nanoparticle. Certain disclosed embodiments comprise enzymatically or chemically digesting a biomolecule conjugated to the nanoparticle, or displacing a biomolecule using ligand-exchange chemistry.
    Type: Grant
    Filed: May 4, 2007
    Date of Patent: March 23, 2010
    Assignee: Ventana Medical Systems, Inc.
    Inventors: Xiao-Bo Chen, Christopher Bieniarz, Michael Farrell
  • Publication number: 20080274463
    Abstract: Disclosed embodiments concern quantifying a biomolecule conjugated to a nanoparticle. Quantifying typically comprises determining the number of biomolecules per nanoparticle. Any suitable biomolecule can be used, including but not limited to, amino acids, peptides, proteins, haptens, nucleic acids, oligonucleotides, DNA, RNA, and combinations thereof. A single type of biomolecule may be conjugated to the nanoparticle, more than one biomolecule of a particular class may be conjugated to the nanoparticle, or two or more classes of biomolecules may be conjugated to the nanoparticle. Certain disclosed embodiments comprise enzymatically or chemically digesting a biomolecule conjugated to the nanoparticle, or displacing a biomolecule using ligand-exchange chemistry.
    Type: Application
    Filed: May 4, 2007
    Publication date: November 6, 2008
    Inventors: Xiao-Bo Chen, Christopher Bieniarz, Michael Farrell
  • Patent number: 7396669
    Abstract: Isolated mammalian Mus81-Eme endonuclease complexes comprise an Mus81 protein portion and an Eme protein portion. A method of identifying a chemical compound that modulates mammalian cellular response to DNA damage comprises contacting a chemical compound to be tested with a biochemical mixture containing an isolated mammalian Mus81-Eme1 endonuclease complex, a source of magnesium ion, and a suitable DNA substrate; measuring the activity level of mammalian Mus81-Eme endonuclease complex in the mixture; comparing the measured activity level to the activity level of a substantially similar mixture of isolated Mus81-Eme1 endonuclease, magnesium ion, and DNA substrate in the absence of the chemical compound to be tested; and selecting a chemical compound that increases or decreases the endonuclease activity. Isolated mammalian Eme1 and Eme2 proteins derived from humans and murine species and isolated nucleic acids encoding the proteins are also described.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: July 8, 2008
    Assignee: The Scripps Research Institute
    Inventors: Michael N. Boddy, Veronique Blais, Xiao-Bo Chen, Clare H. McGowan, Pierre-Henri L. Gaillard, Paul R. Russell
  • Publication number: 20060003434
    Abstract: Isolated mammalian Mus81-Eme endonuclease complexes comprise an Mus81 protein portion and an Eme protein portion. A method of identifying a chemical compound that modulates mammalian cellular response to DNA damage comprises contacting a chemical compound to be tested with a biochemical mixture containing an isolated mammalian Mus81-Eme1 endonuclease complex, a source of magnesium ion, and a suitable DNA substrate; measuring the activity level of mammalian Mus81-Eme endonuclease complex in the mixture; comparing the measured activity level to the activity level of a substantially similar mixture of isolated Mus81-Eme1 endonuclease, magnesium ion, and DNA substrate in the absence of the chemical compound to be tested; and selecting a chemical compound that increases or decreases the endonuclease activity. Isolated mammalian Eme1 and Eme2 proteins derived from humans and murine species and isolated nucleic acids encoding the proteins are also described.
    Type: Application
    Filed: June 30, 2004
    Publication date: January 5, 2006
    Inventors: Michael Boddy, Veronique Blais, Xiao-Bo Chen, Clare McGowan, Pierre-Henri Gaillard, Paul Russell